Cargando…

An extensive phenotypic characterization of the hTNFα transgenic mice

BACKGROUND: Tumor necrosis factor alpha (TNFα) is implicated in a wide variety of pathological and physiological processes, including chronic inflammatory conditions, coronary artery disease, diabetes, obesity, and cachexia. Transgenic mice expressing human TNFα (hTNFα) have previously been describe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayward, Michael D, Jones, Beverly K, Saparov, Arman, Hain, Heather S, Trillat, Anne-Cecile, Bunzel, Michelle M, Corona, Aaron, Li-Wang, Bifang, Strenkowski, Bryan, Giordano, Caroline, Shen, Hai, Arcamone, Emily, Weidlick, Jeffrey, Vilensky, Maria, Tugusheva, Marina, Felkner, Roland H, Campbell, William, Rao, Yu, Grass, David S, Buiakova, Olesia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222242/ https://www.ncbi.nlm.nih.gov/pubmed/18070349 http://dx.doi.org/10.1186/1472-6793-7-13

Ejemplares similares

Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling
por: Valentinis, Barbara, et al.
Publicado: (2019)

Loss of the WNT9a ligand aggravates the rheumatoid arthritis-like symptoms in hTNF transgenic mice
por: Teufel, Stefan, et al.
Publicado: (2021)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
por: Corti, Angelo, et al.
Publicado: (2013)

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
por: Lorusso, D, et al.
Publicado: (2012)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Orphan Nuclear Receptor NR4A2 Is Constitutively Expressed in Cartilage and Upregulated in Inflamed Synovium From hTNF-Alpha Transgenic Mice
por: Lilley, Cullen M., et al.
Publicado: (2022)

Phase I and pharmacodynamic study of high-dose NGR–hTNF in patients with refractory solid tumours
por: Zucali, P A, et al.
Publicado: (2013)

Nonviral gene therapy by electrotransfer of hTNF-α soluble receptor variants: application to the treatment of collagen arthritis
por: Bloquel, C, et al.
Publicado: (2004)

An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model
por: Ubah, Obinna C., et al.
Publicado: (2019)

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies
por: Mammoliti, S., et al.
Publicado: (2011)

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
por: Santoro, A, et al.
Publicado: (2010)

Low-Dose Radiotherapy Ameliorates Advanced Arthritis in hTNF-α tg Mice by Particularly Positively Impacting on Bone Metabolism
por: Deloch, Lisa, et al.
Publicado: (2018)

Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development
por: Ubah, Obinna C., et al.
Publicado: (2017)

Evaluation of hGM-CSF/hTNFα surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model
por: Lai, Shouhua, et al.
Publicado: (2015)

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
por: Gregorc, V, et al.
Publicado: (2009)

TNF-α Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in an Experimental Model of Atherosclerosis
por: Sekenova, Aliya, et al.
Publicado: (2023)

Anxiety-related behaviors without observation of generalized pain in a mouse model of endometriosis
por: Nunez-Badinez, Paulina, et al.
Publicado: (2023)

JAK/STAT inhibitor therapy partially rescues the lipodystrophic autoimmune phenotype in Clec16a KO mice
por: Pandey, Rahul, et al.
Publicado: (2021)

Editorial: Cellular and Molecular Mechanisms at the Proliferation Stage in Wound Healing: From Scarring to Tissue Regeneration
por: Jimi, Shiro, et al.
Publicado: (2021)

The Autoimmune Disorder Susceptibility Gene CLEC16A Restrains NK Cell Function in YTS NK Cell Line and Clec16a Knockout Mice
por: Pandey, Rahul, et al.
Publicado: (2019)

Copper Deficiency in the Lungs of TNF-α Transgenic Mice
por: Liu, Liu, et al.
Publicado: (2016)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
por: Li, Xuefei, et al.
Publicado: (2023)

Recent Advances in the Controlled Release of Growth Factors and Cytokines for Improving Cutaneous Wound Healing
por: Nurkesh, Ayan, et al.
Publicado: (2020)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Découverte de la matière
por: Trillat, Jean Jacques
Publicado: (1956)

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols
por: Douni, Eleni, et al.
Publicado: (2004)

A monocyte‐TNF‐endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade
por: Solovey, Anna, et al.
Publicado: (2017)

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine
por: Sultankulov, Bolat, et al.
Publicado: (2019)

Sequential Delivery of Cryogel Released Growth Factors and Cytokines Accelerates Wound Healing and Improves Tissue Regeneration
por: Jimi, Shiro, et al.
Publicado: (2020)

A Novel Autologous Micrografts Technology in Combination with Negative Pressure Wound Therapy (NPWT) for Quick Granulation Tissue Formation in Chronic/Refractory Ulcer
por: Takagi, Satoshi, et al.
Publicado: (2020)

Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction
por: Kim, Yevgeniy, et al.
Publicado: (2021)

Collagen-derived dipeptide Pro-Hyp administration accelerates muscle regenerative healing accompanied by less scarring after wounding on the abdominal wall in mice
por: Jimi, Shiro, et al.
Publicado: (2021)

Peptide-Based Drug Delivery Systems
por: Berillo, Dmitriy, et al.
Publicado: (2021)

Recent Advances in Gene Therapy for Cardiac Tissue Regeneration
por: Kim, Yevgeniy, et al.
Publicado: (2021)

A novel mouse wound model for scar tissue formation in abdominal muscle wall
por: JIMI, Shiro, et al.
Publicado: (2021)

Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
por: Raziyeva, Kamila, et al.
Publicado: (2022)

CLEC16A regulates splenocyte and NK cell function in part through MEK signaling
por: Pandey, Rahul, et al.
Publicado: (2018)

Acceleration of Skin Wound-Healing Reactions by Autologous Micrograft Tissue Suspension
por: Jimi, Shiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8e08nt395g0e1jjdgci35a09q6